GDF2
From Wikipedia, the free encyclopedia
|
growth differentiation factor 2
|
|
| Identifiers | |
| Symbol | GDF2 |
| Alt. Symbols | BMP-9, BMP9 |
| Entrez | 2658 |
| HUGO | 4217 |
| OMIM | 605120 |
| PDB | 1ZKZ |
| RefSeq | NM_016204 |
| UniProt | Q9UK05 |
| Other data | |
| Locus | Chr. 11 q11.22 |
Growth differentiation factor 2 (GDF2) is a protein also known as bone morphogenetic protein (BMP)-9 that belongs to the transforming growth factor beta superfamily. It has a role in inducing and maintaining the ability of embryonic basal forebrain cholinergic neurons (BFCN) to respond to a neurotransmitter called acetylcholine; BFCN are important for the processes of learning, memory and attention.[1] GDF2 is also important for the maturation of BFCN.[1] Another role of GDF2 has been recently suggested. GDF2 is a potent inducer of hepcidin (a cationic peptide that has a antimicrobial properties) in liver cells (hepatocytes) and can regulate iron metabolism.[2] The physiological receptor of GDF2 is thought to be activin receptor-like kinase 1, ALK1 (also called ACVRL1), an endothelial-specific type I receptor of the TGF-beta receptor family.[3]
GDF2 is one of the most potent BMPs to induce orthotopic bone formation in vivo. BMP2, a blocker of most BMPs seems not to affect GDF2. [4]
[edit] References
- ^ a b Lopez-Coviella I, Follettie M, Mellott T, Kovacheva V, Slack B, Diesl V, Berse B, Thies R, Blusztajn J (2005). "Bone morphogenetic protein 9 induces the transcriptome of basal forebrain cholinergic neurons". Proc Natl Acad Sci U S A 102 (19): 6984–9. doi:. PMID 15870197.
- ^ Truksa J, Peng H, Lee P, Beutler E (2006). "Bone morphogenetic proteins 2, 4, and 9 stimulate murine hepcidin 1 expression independently of Hfe, transferrin receptor 2 (Tfr2), and IL-6". Proc Natl Acad Sci U S A 103 (27): 10289–93. doi:. PMID 16801541.
- ^ David L, Mallet C, Mazerbourg S, Feige J, Bailly S (2007). "Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1, ALK1 (also called ACVRL1) in endothelial cells". Blood 109 (5): 1953–61. doi:. PMID 17068149.
- ^ Q Kang, MH Sun, H Cheng, Y Peng, AG Montag, AT Deyrup, W Jiang, HH Luu, J Luo, JP Szatkowski, P Vanichakarn, JY Park, Y Li, RC Haydon and T-C He (2004). "Characterization of the distinct orthotopic bone-forming activity of 14 BMPs using recombinant adenovirus-mediated gene delivery". Gene Therapy 11 (17): 1312–20. doi:. PMID 15269709.
|
||||||||||||||||||||

